Top stocks in focus today: Idea, RCom, SBI, Vedanta, Biocon, Quess Corp, Lupin
These companies will be in focus during trade today based on recent and latest news developments.
Biocon and Mylan’s Biosimilar Pegfilgrastim received US FDA approval.
Idea Cellular gets approval from DoT to increase FDI limit from 67.5% to 100%.
A penalty of Rs7cr has been imposed on SBI under FEMA 1999.
Maruti Suzuki’s total production up 22% to 1.84 lakh units in May.
RCom won’t pay interest on NCD to JLF until restructuring process ends.
Vedanta will add 1.5 MTPA of iron ore production with potential up to 2.5MTPA to its capacity after ESL acquisition. Vedanta pays Rs5,300 cr for acquisition.
Bank of India files application with NCLT for initiation of corporate insolvency resolution process against Haitan Electricals.
Quess Corp approve acquisition of additional 8% equity in Simpliance Technologies.
Sudarshan Chemicals divests its plastic masterbatch business- Prescient Color Ltd. and plans to invest Rs1000cr over next 5 years.
Sunteck Realty increases its investment limits by RPFI/FII from 24% to 49%.
GE Shipping gets contract to sell its Bulk Carrier of 52,200 deadweight tonnage.
Lupin receives US FDA approval for Nystatin and Triamcinolone Acetonide Cream USP, used in the treatment of cutaneous candidiasis. Has market size of $62.2 million annually.
Multiple investors will meet the Indian Hotels‘ management in an investors’ conference on June 5.
your financial future with best service advantages of Bonaz Capital Private Limited and here we provide best recommendations for you SUBSCRIBE NOW >> Bonaz Capital